BMC Medical Genetics

official impact factor 2.44

Open Access Research article

Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles

Delphine Fauvert1,2, Isabelle Brun-Heath1, Anne-Sophie Lia-Baldini3,4, Linda Bellazi1, Agnès Taillandier2, Jean-Louis Serre1, Philippe de Mazancourt1 and Etienne Mornet1,2*

Author Affiliations

1 Unité de pathologie cellulaire et génétique EA2493, Université de Versailles-Saint Quentin en Yvelines, 78035 Versailles, France

2 Laboratoire SESEP, Centre Hospitalier de Versailles, 78150 Le Chesnay, France

3 Département de Génie Biologique, Institut Universitaire de Technologies du Limousin, 87000 Limoges, France

4 Laboratoire de Biomolécules et thérapies antitumorales EA4021, Centre Hospitalier Universitaire de Limoges, Limoges, France

For all author emails, please log on.

BMC Medical Genetics 2009, 10:51 doi:10.1186/1471-2350-10-51

Published: 6 June 2009

Abstract

Background

Mild hypophosphatasia (HPP) phenotype may result from ALPL gene mutations exhibiting residual alkaline phosphatase activity or from severe heterozygous mutations exhibiting a dominant negative effect. In order to determine the cause of our failure to detect a second mutation by sequencing in patients with mild HPP and carrying on a single heterozygous mutation, we tested the possible dominant effect of 35 mutations carried by these patients.

Methods

We tested the mutations by site-directed mutagenesis. We also genotyped 8 exonic and intronic ALPL gene polymorphisms in the patients and in a control group in order to detect the possible existence of a recurrent intronic mild mutation.

Results

We found that most of the tested mutations exhibit a dominant negative effect that may account for the mild HPP phenotype, and that for at least some of the patients, a second mutation in linkage disequilibrium with a particular haplotype could not be ruled out.

Conclusion

Mild HPP results in part from compound heterozygosity for severe and moderate mutations, but also in a large part from heterozygous mutations with a dominant negative effect.